I AM A MD ANESTHESIIA POST GRADUATE STUDYING IN A RGUHS AFFILIATED COLLEGE .I HaVE MY EXAMS THIS SEPTEMBER AND NEEDD HELP WITH ANSWERS TO CERTAIN QUESTIONS. THEY ARE EACH TO BE WRITTEN IN A 10 MARKER FORMAT WITH ACCURATE AND RELEVENT HEADINGS. MIN 5000 WORD AND IT SHOULD BE 5 PAGES LONG AT LEAST. WHERE RELEVENCE ADD NOTEES ON ANESTHETIC SPECIALITIES. TAKE REFERENCES FROM STANDARD ANETHESIA TEXTBOOOKS AND ARTCLES. I ALSO WANT YOU TO GENEREATE FLOWCHARTS AND SIMPLE DIAGRAMS AND PICTURES AS IT YEILDS MORE MARKS, DONT WRRY ABOUT COPY RIGHT INFRINGMENT , ITS ALL FOR PERSONAL USE. DETAIL ORIENTED AND CORRECT DRUG DOSAGES.
Physiological changes during hypothermia
hypothermia physiological effects anesthesia
physiological changes hypothermia anesthesia 10 marker cardiovascular respiratory coagulation
https://derangedphysiology.com/main/cicm-primary-exam/thermo…
Medical flowchart showing classification and physiological changes during hypothermia. Show three stages: Mild (32-35°C), Moderate (28-32°C), Severe (below 28°C). For each stage list key physiological changes in cardiovascular, respiratory, neurological, metabolic, and hematological systems. Clean medical diagram style with color coding per stage.
Medical diagram showing ECG changes during hypothermia: Normal ECG at top, then progressive changes showing sinus bradycardia, prolonged PR interval, J wave (Osborn wave) at QRS-ST junction, atrial fibrillation, ventricular fibrillation at the bottom. Label each abnormality clearly. Clean clinical ECG diagram style.
400, message: Got more than 4194304 bytes when reading: b'data: {"candidates": [{"content": {"role": "model","parts": [{"inlineData": {"mimeType": "image/png"...'.
We encountered an error while processing your request. Please try again or reach out to us for help.
physiological changes in pregnancy
physiological adaptations pregnancy anesthesia
physiological changes pregnancy anesthesia cardiovascular respiratory hematological renal 10 marker RGUHS MD anesthesia
A detailed medical summary table/diagram titled "Physiological Changes in Pregnancy - Summary Table" showing all organ system changes. Include rows for: Cardiovascular (CO +40%, HR +20%, SV +30%, SVR -15%, BP slightly decreased), Respiratory (FRC -20%, MV +50%, TV +40%, PaCO2 28-32 mmHg, O2 consumption +20-50%), Hematological (Blood volume +35%, Plasma volume +55%, Hb decreased to ~11.6 g/dL, hypercoagulable state, WBC leukocytosis), Renal (GFR +50%, Renal blood flow +60-80%, serum creatinine decreased), CNS (MAC -40%, local anesthetic dose requirements reduced 30%, epidural venous engorgement), Gastrointestinal (LES incompetence, aspiration risk, delayed gastric emptying in labor). Use a clean clinical medical diagram style with color-coded rows per system.
Medical flowchart diagram titled "Aortocaval Compression Syndrome in Pregnancy - Mechanism and Management". Show the mechanism: gravid uterus compresses IVC and Aorta in supine position → decreased venous return → decreased cardiac output → hypotension and uteroplacental insufficiency. Show management steps: left lateral tilt 15 degrees, wedge under right hip, IV fluids, vasopressors (ephedrine/phenylephrine). Include a simple anatomical illustration showing the pregnant uterus compressing the inferior vena cava with the patient in supine position versus tilted position. Clean medical diagram style.
Medical diagram showing respiratory changes in pregnancy. Show a side-view silhouette of a pregnant woman with labeled respiratory volume changes: tidal volume increased 40%, FRC decreased 20%, expiratory reserve volume decreased, residual volume decreased, total lung capacity slightly decreased. Show lung volume spirometry bars comparing pregnant vs non-pregnant. Include labeled arrows showing: diaphragm elevation by enlarging uterus, increased anteroposterior chest diameter. Also show a table with arterial blood gas values: PaCO2 30 mmHg (vs normal 40), PaO2 103 mmHg, HCO3 20 mEq/L (vs normal 24), pH 7.44. Clean anatomical medical style.
Medical flowchart titled "Anesthetic Implications of Physiological Changes in Pregnancy" showing key anesthetic considerations organized by system. Cardiovascular: left lateral tilt, vasopressor use (ephedrine 5-10mg IV, phenylephrine 50-100mcg IV), avoid aortocaval compression. Respiratory: rapid desaturation risk, preoxygenation mandatory 3-5 mins, RSI technique, difficult airway anticipate. CNS: MAC reduced 40%, reduce inhalational agent doses, local anesthetic doses reduced 30% for epidural. Gastrointestinal: aspiration risk, sodium citrate 30mL PO, ranitidine 150mg, metoclopramide 10mg, RSI with cricoid pressure. Clean clinical flowchart with colored boxes per system.

Criteria for diagnosing pathological cardiac disease in pregnancy:
- Diastolic murmurs
- Systolic murmur Grade 3 or above
- Unequivocal cardiac enlargement on X-ray
- Severe arrhythmias, atrial fibrillation, or flutter

Anesthetic Note - Aortocaval Compression:
- All pregnant patients beyond 20 weeks should be positioned with left lateral uterine displacement (LUD)
- A 15-degree wedge under the right hip is the standard method
- During cesarean section under regional or general anesthesia, uterine displacement must be maintained until the baby is delivered
- First-line vasopressor: Phenylephrine 50-100 mcg IV boluses (preferred - does not reduce uteroplacental blood flow and reduces fetal acidosis compared to ephedrine)
- Second-line: Ephedrine 5-10 mg IV (retains some utility when bradycardia accompanies hypotension)
- Prophylactic phenylephrine infusion (0.25-0.5 mcg/kg/min) is recommended with spinal anesthesia for cesarean delivery
| Parameter | Change | Clinical Significance |
|---|---|---|
| Tidal Volume (TV) | +40% | Increased minute ventilation |
| Respiratory Rate (RR) | +15% | Mild increase |
| Minute Ventilation (MV) | +50% | Respiratory alkalosis |
| Functional Residual Capacity (FRC) | -20% | Rapid desaturation - most critical |
| Expiratory Reserve Volume (ERV) | -25% | Contributes to FRC reduction |
| Residual Volume (RV) | -15% | Contributes to FRC reduction |
| Vital Capacity (VC) | Unchanged | |
| Total Lung Capacity (TLC) | Slightly decreased | Diaphragm elevated ~4 cm |
| Inspiratory Reserve Volume | +5% | Compensatory |
| Airway Resistance | -35% | Bronchodilation from progesterone |
| Closing Capacity (CC) | Unchanged | FRC may fall below CC at term |

| Parameter | Pregnant | Non-pregnant |
|---|---|---|
| PaCO2 | 28-32 mmHg | 40 mmHg |
| PaO2 | 103-107 mmHg | 100 mmHg |
| HCO3 | 20-21 mEq/L | 24 mEq/L |
| pH | 7.42-7.44 | 7.40 |
| P50 | 30 mmHg | 27 mmHg |
Critical Anesthetic Note - Rapid Desaturation: The combination of:
- Decreased O2 reserve (FRC -20%)
- Increased O2 consumption (+20-50%)
- Potential airway difficulty
...means that a pregnant patient at term will desaturate to dangerous SpO2 levels within 2-3 minutes of apnea (vs 4-5 minutes in a non-pregnant adult).Mandatory protocol:
- Preoxygenation: 3-5 minutes of tidal breathing of 100% O2 (target end-tidal O2 > 90%), or 4 vital capacity breaths in 30 seconds
- Rapid Sequence Induction (RSI) with cricoid pressure (Sellick's maneuver) for all general anesthesia after 18-20 weeks
- Consider apneic oxygenation (10-15 L/min O2 via nasal cannula during laryngoscopy) to extend safe apnea time
- Airway equipment: smaller endotracheal tube (6.0-6.5 mm ID) due to supraglottic edema
| Change | Mechanism | Effect |
|---|---|---|
| Decreased lower esophageal sphincter (LES) tone | Progesterone relaxes smooth muscle; estrogen potentiates | Increased reflux risk |
| Gastric displacement | Uterus pushes stomach cephalad and rotates axis | LES displaced above diaphragm (intrathoracic) |
| Increased intragastric pressure | Uterine compression of stomach | Increased aspiration tendency |
| Placental gastrin secretion | Placenta produces gastrin | Increased HCl secretion, reduced gastric pH |
| Increased heartburn and reflux | Combination of above | Esophagitis in >70% of parturients |
Anesthetic Note - Aspiration Prophylaxis Protocol: For all pregnant patients requiring GA (and ideally for emergency CS under regional):
- Sodium citrate 0.3M, 30 mL PO - immediately before induction (non-particulate antacid, raises gastric pH)
- Ranitidine 150 mg PO 8-hourly (or 50 mg IV - H2 blocker, reduces acid secretion)
- Metoclopramide 10 mg IV - prokinetic + raises LES tone
- RSI technique: Propofol 2 mg/kg + Succinylcholine 1.5 mg/kg IV (cricoid pressure 20-30 N applied after induction, maintained until intubation confirmed)
| Parameter | Change | Absolute Values |
|---|---|---|
| Total blood volume | +35% | ~90 mL/kg (term) |
| Plasma volume | +55% | Peaks at 32-34 weeks |
| Red cell mass | +25% | |
| Hemoglobin | Decreased | ~11.6 g/dL (normal; <11 g/dL = true anemia) |
| Hematocrit | Decreased | ~33-35% |
| Blood viscosity | Decreased | -20% |
| Platelets | -10% | 150,000-400,000/mm3 (mild dilutional thrombocytopenia) |
Anesthetic Note - Coagulation and Regional Anesthesia:
- Platelet count > 70,000-80,000/mm3 is generally considered safe for neuraxial blockade (ASRA guidelines; institutional protocols vary, many require >100,000)
- Pre-eclampsia can rapidly cause thrombocytopenia - check platelet count before regional anesthesia in pre-eclamptic patients
- In patients on low molecular weight heparin (LMWH): neuraxial block safe after 12 hours (prophylactic dose) or 24 hours (therapeutic dose) from last injection
| Parameter | Change |
|---|---|
| Renal plasma flow | +60-80% by mid-pregnancy |
| Glomerular filtration rate (GFR) | +50% (by 3rd month) |
| Serum creatinine | Decreased (0.4-0.8 mg/dL in pregnancy) |
| Blood urea nitrogen (BUN) | Decreased (8-12 mg/dL) |
| Serum uric acid | Decreased early; increases in late pregnancy |
| Plasma osmolality | Decreased by 8-10 mOsm/kg |
Anesthetic Note - Succinylcholine Duration: Despite the 25-30% reduction in pseudocholinesterase activity, the clinical duration of succinylcholine is not significantly prolonged in normal pregnant patients because the increased volume of distribution compensates. However, in patients with underlying pseudocholinesterase deficiency (dibucaine number <70), the reduced enzyme activity can lead to markedly prolonged neuromuscular blockade.Succinylcholine dose for RSI in pregnancy: 1.5 mg/kg IV (higher dose preferred due to expanded VD and to ensure rapid, reliable intubating conditions)
| Hormone | Change | Key Effect |
|---|---|---|
| Progesterone | 20-fold increase | Respiratory stimulation, smooth muscle relaxation, decreased MAC, sedation |
| Estrogen | 10-fold increase | Mucosal edema, hepatic protein synthesis changes, increased CBG, TBG |
| hCG | Peaks at 10-12 weeks | Nausea and vomiting in first trimester; maintains corpus luteum |
| Cortisol | Increased | Insulin resistance, striae |
| Relaxin | Increased | Softens pubic symphysis, pelvic ligaments, cervical ripening |
| Prolactin | 10-fold increase at term | Lactation preparation |
| Aldosterone | Increased | Sodium and water retention |
| Parameter | Change | Implication |
|---|---|---|
| Volume of distribution (Vd) | Increased (+35% blood volume) | Higher loading doses may be needed |
| Protein binding | Decreased (albumin falls) | Increased free drug fraction of protein-bound drugs |
| Hepatic metabolism | Increased CYP3A4, decreased other enzymes | Variable drug clearance |
| Pseudocholinesterase | -25-30% | Succinylcholine (minor effect clinically) |
| GFR | +50% | Increased renal clearance of renally excreted drugs |
| MAC | -40% | Reduce volatile agent doses |
| Local anesthetic requirement | -30% | Reduce epidural and spinal doses |
| Stage | CO Change | O2 Consumption | Other |
|---|---|---|---|
| First stage | +15% above prelabor | +40% | Pain drives hyperventilation; PaCO2 may fall to <20 mmHg |
| Second stage | +50% above prelabor | +75% | Pushing, Valsalva causes further CO changes |
| Immediately postpartum | +60-80% surge | Returns toward normal | Autotransfusion; IVC decompression |

| System | Key Change | Anesthetic Implication | Specific Precaution |
|---|---|---|---|
| Cardiovascular | CO +40%, SVR -15% | Hypotension common under regional/GA | Left uterine displacement, phenylephrine infusion |
| Respiratory | FRC -20%, O2 consumption +50% | Rapid desaturation | Mandatory preoxygenation, RSI |
| Airway | Mucosal edema, Mallampati worsens | Difficult airway | Smaller ETT (6.0-6.5mm), have difficult airway cart ready |
| CNS | MAC -40% | Less volatile agent needed | Adjust MAC accordingly; awakeness risk |
| CNS | LA sensitivity increased | Smaller epidural/spinal doses | Reduce doses 30% for epidural; careful titration |
| GI | LES incompetence, full stomach | Aspiration risk | Sodium citrate 30 mL, ranitidine 50 mg IV, RSI with cricoid pressure |
| Hematological | Dilutional anemia, hypercoagulable | Manage blood loss; DVT risk | Check CBC, coagulation before regional; VTE prophylaxis postpartum |
| Renal | GFR +50%, creatinine down | Normal creatinine may be deceiving | Use 0.5 mg/dL as upper normal in pregnancy |
| Hepatic | Pseudocholinesterase -25-30% | Minimal clinical impact on succinylcholine | Monitor NMB if pseudocholinesterase deficiency suspected |
| Drug | Indication | Dose |
|---|---|---|
| Phenylephrine | Spinal hypotension (first line) | 50-100 mcg IV bolus; infusion 0.25-0.5 mcg/kg/min |
| Ephedrine | Spinal hypotension with bradycardia | 5-10 mg IV bolus |
| Succinylcholine | RSI in pregnancy | 1.5 mg/kg IV |
| Propofol | Induction for GA | 1.5-2 mg/kg IV (use 1.5 in hemodynamically compromised) |
| Sodium citrate | Aspiration prophylaxis | 0.3M, 30 mL PO - immediately before induction |
| Ranitidine | H2 blocker - aspiration prophylaxis | 150 mg PO OR 50 mg IV slowly |
| Metoclopramide | Prokinetic, raises LES tone | 10 mg IV |
| Bupivacaine (spinal for CS) | Subarachnoid block | 0.5% hyperbaric bupivacaine 1.5-2 mL + fentanyl 25 mcg + morphine 100-200 mcg |
| Bupivacaine (epidural labor) | Labor analgesia | 0.1% bupivacaine + fentanyl 2 mcg/mL (PCEA) |
| Oxytocin | Uterotonic post-delivery | 5 IU slow IV (do NOT give as rapid bolus - causes hypotension) |
| Atropine | Bradycardia | 0.6 mg IV |
| Ondansetron | PONV / spinal nausea | 4-8 mg IV |
Examiner's Tip (RGUHS 10-marker): This topic is frequently asked in combination with "obstetric anesthesia for cesarean section" or "anesthesia in pre-eclampsia." Always anchor each system's change to a specific anesthetic implication - examiners award extra marks for applied knowledge, not just listed facts. Drug doses with correct units always gain marks.
Intra-operative estimation of blood loss
intraoperative blood loss estimation methods accuracy
intraoperative estimation of blood loss methods visual gravimetric photometric colorimetric allowable blood loss formula anesthesia 10 marker
https://link.springer.com/article/10.1186/s12893-024-02699-3
ATLS hemorrhagic shock classification blood loss class I II III IV anesthesia management transfusion trigger perioperative
Medical flowchart titled "Methods of Intraoperative Blood Loss Estimation" showing a hierarchical diagram with two main branches: 1) QUALITATIVE/CLINICAL METHODS including Visual Estimation (sponge counting, suction canister, surgical field assessment), Clinical Signs (HR, BP, urine output, skin color), 2) QUANTITATIVE METHODS including Gravimetric Method (weighing sponges, 1g=1mL formula), Colorimetric/Photometric Method (spectrophotometry, Triton app), Mathematical Formulas (MABL formula, Moore formula, Hb-based formula). Include a third branch: LABORATORY MONITORING (serial Hb/Hct, coagulation, TEG/ROTEM). Each method labeled with advantages and limitations. Clean medical flowchart with color coding.
Medical table diagram titled "ATLS Classification of Hemorrhagic Shock" with 5 columns (Parameter, Class I, Class II, Class III, Class IV) and rows showing: Blood Loss mL (less than 750, 750-1500, 1500-2000, greater than 2000), Blood Loss % (less than 15%, 15-30%, 30-40%, greater than 40%), Heart Rate (less than 100, 100-120, 120-140, greater than 140), Blood Pressure (Normal, Normal, Decreased, Very low), Pulse Pressure (Normal/increased, Decreased, Decreased, Decreased), Respiratory Rate (14-20, 20-30, 30-40, greater than 35), Urine Output mL/hr (greater than 30, 20-30, 5-15, Negligible), Mental Status (Slightly anxious, Mildly anxious, Anxious/confused, Confused/lethargic), Fluid Replacement (Crystalloid, Crystalloid, Blood+crystalloid, Blood+crystalloid). Use color gradient from green for Class I to red for Class IV. Clean medical table format.
Medical diagram titled "Calculation of Maximum Allowable Blood Loss (MABL) - Step by Step". Show a step-by-step flowchart: Step 1: Estimate Blood Volume (EBV) using table (Premature infant 90-100 mL/kg, Term neonate 80-90 mL/kg, Infant 75-80 mL/kg, Child 70-75 mL/kg, Adult male 75 mL/kg, Adult female 65 mL/kg, Obese BMI 30: 60 mL/kg). Step 2: Determine Initial Hematocrit (HCTi). Step 3: Set Target/Threshold Hematocrit (HCTf) - typically 21-24% for healthy adults, 28-30% for cardiac/elderly. Step 4: Apply Formula: MABL = EBV x (HCTi - HCTf) / HCTi. Show a worked example: 70kg adult male, HCTi=42%, HCTf=21%, EBV=5250mL, MABL=2625mL. Step 5: Management algorithm based on blood loss vs MABL. Clean mathematical medical diagram style.

A. QUALITATIVE / CLINICAL METHODS
1. Visual estimation
2. Clinical signs and hemodynamic monitoring
3. ATLS hemorrhagic shock classification
B. QUANTITATIVE METHODS
1. Gravimetric method (weighing)
2. Colorimetric / photometric method
3. Spectrophotometric method
4. Mathematical formulae (MABL, Moore, Hb-based)
C. LABORATORY METHODS
1. Serial hemoglobin / hematocrit
2. Coagulation studies (PT, aPTT, fibrinogen)
3. Point-of-care coagulation (TEG / ROTEM)
4. Arterial blood gas with lactate
D. ADVANCED / EMERGING METHODS
1. Near-infrared spectroscopy (NIRS)
2. Artificial intelligence - image-based (Triton system)
3. Ultrasound-based assessment (IVC collapsibility, FAST)
| Sponge Type | Approximate Blood Absorption |
|---|---|
| 4 x 4 gauze (fully soaked) | ~10 mL |
| Ray-Tec / gauze sponge (fully soaked) | ~10-20 mL |
| Laparotomy sponge (fully soaked) | ~100-150 mL |
| Small swab | ~5 mL |
Anesthetic Note: Even experienced anesthesiologists underestimate blood loss, particularly in obstetric hemorrhage. A structured quantitative approach (weighing + suction) is strongly recommended in high-risk procedures such as LSCS, cardiac surgery, hepatic resection, and trauma laparotomy.
| Parameter | Significance |
|---|---|
| Heart rate | First sign of significant hemorrhage - tachycardia (>100 bpm) |
| Blood pressure | Late sign - MAP falls only after >30% blood loss in young patients |
| Pulse pressure | Narrows early (vasomotor tone rises to maintain systolic BP) |
| Central venous pressure (CVP) | Decreases with hypovolemia; trends more useful than absolute values |
| Urine output | Target >0.5 mL/kg/h - organ perfusion marker |
| End-tidal CO2 | Decreases with severe hemorrhage and reduced cardiac output |
| Pulse oximetry waveform | Diminished amplitude / dampened waveform with low CO |
| Stroke volume variation (SVV) | Reliable indicator of fluid responsiveness in mechanically ventilated patients; SVV >13% suggests fluid responsiveness |
| Pulse pressure variation (PPV) | Similar utility to SVV for predicting response to volume |
Anesthetic Note - Pitfall: In the anesthetized patient, the usual autonomic signs of hemorrhagic shock (tachycardia, sweating, agitation) are masked. The anesthesiologist must rely more heavily on invasive hemodynamic monitoring, urine output trends, and laboratory values than in the awake patient.

| Parameter | Class I | Class II | Class III | Class IV |
|---|---|---|---|---|
| Blood loss (mL) | <750 | 750-1500 | 1500-2000 | >2000 |
| Blood loss (%) | <15% | 15-30% | 30-40% | >40% |
| Heart rate | <100 | >100 | >120 | >140 |
| Blood pressure | Normal | Normal | Decreased | Very low |
| Pulse pressure | Normal/increased | Decreased | Decreased | Decreased |
| Respiratory rate | 14-20 | 20-30 | 30-40 | >35 |
| Urine output (mL/h) | >30 | 20-30 | 5-15 | Negligible |
| CNS/Mental status | Slightly anxious | Mildly anxious | Anxious, confused | Confused, lethargic |
| Fluid replacement | Crystalloid | Crystalloid | Crystalloid + blood | Crystalloid + blood |
Blood in sponges (mL) = [Wet weight (g) - Dry weight (g)] / 1.06
≈ Wet weight (g) - Dry weight (g) [practical approximation]
| Sponge | Dry weight |
|---|---|
| 4x4 gauze | 2-3 g |
| Ray-Tec | 3-5 g |
| Laparotomy sponge | 25-30 g |
| Patient Category | EBV (mL/kg) |
|---|---|
| Premature infant | 90-100 |
| Term neonate | 80-90 |
| Infant (<1 year) | 75-80 |
| Child (1-12 years) | 70-75 |
| Adolescent (12-18 years) | 70 |
| Adult male | 75 |
| Adult female | 65 |
| Obese adult (BMI 30) | 60 |
| Obese adult (BMI 40) | 55 |
| Obese adult (BMI 50) | 50 |

MABL = EBV × (HCTi - HCTf) / HCTi
Patient: 70 kg adult male, Hct = 42%, target Hct = 21%
EBV = 70 kg × 75 mL/kg = 5250 mL
MABL = 5250 × (42 - 21) / 42
MABL = 5250 × 0.5 = 2625 mL
| Patient Type | Transfusion Threshold Hct | Hemoglobin Equivalent |
|---|---|---|
| Healthy young adult | 21-24% | 7-8 g/dL |
| Elderly / coronary artery disease | 28-30% | 9-10 g/dL |
| Cardiac disease, poor LV function | 30% | 10 g/dL |
| Premature/term neonate | 30-35% | 10-11 g/dL |
| Cyanotic CHD | Higher, individualized | Discuss with cardiologist |
Current transfusion guidelines (ASA, SABM): A "restrictive" strategy with Hb trigger of 7-8 g/dL (Hct 21-24%) is recommended for stable, non-cardiac patients. A "liberal" trigger of Hb 9-10 g/dL is used for those with cardiac disease, poor cardiopulmonary reserve, or active myocardial ischemia.
Blood Loss (mL) = EBV × (Hbi - Hbf) / Hb_average
Blood loss ≈ EBV × (HCTi - HCTcurrent) / HCTi
| Parameter | Measures | Normal Value |
|---|---|---|
| R time (reaction time) | Enzymatic clot initiation | 5-10 min |
| K time | Fibrinogen contribution to clot strength | 1-3 min |
| Alpha angle (α) | Speed of clot strengthening | 53-72° |
| MA (maximum amplitude) | Platelet + fibrin clot strength | 51-69 mm |
| LY30 | Fibrinolysis at 30 min | <8% |
| CI (coagulation index) | Overall coagulation status | -3 to +3 |
Anesthetic Note - TEG/ROTEM in massive hemorrhage: TEG/ROTEM allow targeted, goal-directed transfusion therapy - giving the right blood product for the specific coagulopathic defect rather than empirical FFP/platelet transfusion. This reduces overall blood product use and transfusion-related complications.
| Blood Loss | Replacement | Ratio |
|---|---|---|
| Up to 15% EBV | Crystalloid (Ringer's Lactate or Normal Saline) | 3:1 (crystalloid: blood loss) |
| 15-30% EBV | Crystalloid ± Colloid | 3:1 crystalloid; 1:1 colloid |
| Approaching MABL | Start blood transfusion (pRBC) | 1:1 (pRBC: blood loss) |
| >MABL | pRBC + FFP + Platelets; Massive Transfusion Protocol | 1:1:1 ratio |
Volume of pRBC required (mL) =
Desired ΔHb (g/dL) × EBV (mL) / Hb of donor unit
Simple approximation:
4-5 mL/kg of pRBC raises hemoglobin by 1 g/dL
| Component | Target Ratio | Dose |
|---|---|---|
| pRBC | 1 unit | 250-350 mL |
| FFP | 1:1 with pRBC | 10-15 mL/kg |
| Platelets | 1 pool / 4-6 pRBC | 1 apheresis unit (~250 mL) |
| Cryoprecipitate | If fibrinogen <1.5 g/L | 2-3 pools (10 units) |
| Tranexamic acid (TXA) | Within 3 hours of injury | 1g IV over 10 min, then 1g over 8h |
| Calcium chloride | Per 4 units pRBC | 1g IV (chelation by citrate in blood products) |
TXA (Tranexamic Acid) Key Dose: CRASH-2 trial established 1g IV bolus over 10 minutes, then 1g infusion over 8 hours for trauma hemorrhage. Must be given within 3 hours of injury onset - after this, mortality risk increases. WOMAN trial confirmed benefit in postpartum hemorrhage: 1g IV, repeat if bleeding continues at 30 min.
Evidence: Quantitative blood loss assessment (QBL) reduces the risk of severe maternal morbidity compared to visual estimation. ACOG (2019) and WHO (2023) both recommend QBL as routine practice in obstetric units.
PREOPERATIVE PLANNING
├── Calculate EBV (Nadler or body-weight formula)
├── Record baseline Hb/Hct
├── Calculate MABL [= EBV × (HCTi - HCTf) / HCTi]
├── Type and screen/crossmatch blood as per anticipated surgery
└── Establish IV access, arterial line for major procedures
INTRAOPERATIVE MONITORING
├── Visual estimate: sponge count + suction canister (subtract irrigation)
├── Gravimetric method: weigh sponges at regular intervals
├── Hemodynamic monitoring: HR, BP, CVP, urine output
├── PPV/SVV on ventilated patients (fluid responsiveness)
├── Serial ABG/Hb (if ongoing significant loss)
└── TEG/ROTEM if coagulopathy suspected
DECISION TO TRANSFUSE
├── EBL < 15% → Crystalloid 3:1
├── EBL 15-30% → Crystalloid ± Colloid
├── EBL approaching MABL → Start pRBC
├── EBL > MABL → pRBC + FFP + Platelets
└── EBL > 1 EBV → Activate MTP; add TXA 1g IV + Calcium
| Method | Accuracy | Speed | Cost | Equipment | Best Use |
|---|---|---|---|---|---|
| Visual estimation | Low-moderate | Very fast | Nil | Nil | Routine, any setting |
| Gravimetric | Moderate-good | Fast | Low | Weighing scale | Routine-major surgery |
| Colorimetric (Triton) | High | Fast | Moderate | Smartphone | High-risk surgery, research |
| Spectrophotometric | Highest | Slow | High | Lab equipment | Research/gold standard |
| MABL formula | Good (planning) | Pre-op | Nil | Calculator | Preoperative planning |
| Serial Hb/Hct | Good (real-time) | Moderate | Low | POC analyzer | All cases |
| TEG/ROTEM | Excellent (coag) | 10-20 min | High | Dedicated analyzer | Massive hemorrhage |
| SpHb (Masimo) | Moderate (trends) | Real-time | Moderate | CO-oximeter | Trend monitoring |
| Drug | Indication | Dose |
|---|---|---|
| Tranexamic acid (TXA) | Reducing surgical blood loss | 1g IV over 10 min (then 1g over 8h); Give within 3 hours |
| Calcium chloride 10% | Hypocalcemia with massive transfusion | 1g IV slowly per 4 units pRBC |
| Adrenaline (epinephrine) | Anaphylaxis/cardiac arrest during massive hemorrhage | 1 mg IV (cardiac arrest); 10-20 mcg IV bolus (hemodynamic compromise) |
| Vasopressin | Refractory vasodilatory shock with hemorrhage | 0.03-0.04 units/min infusion |
| Noradrenaline | Maintaining MAP during resuscitation | 0.1-0.3 mcg/kg/min infusion |
| Desmopressin (DDAVP) | Uremic platelet dysfunction, von Willebrand disease | 0.3 mcg/kg IV over 30 min |
| Fibrinogen concentrate | Low fibrinogen (<1.5 g/L) | 2-4g IV |
| Protamine | Heparin reversal (post-CPB) | 1mg per 100 units heparin IV |
| Factor VII (rFVIIa, Novoseven) | Refractory, life-threatening coagulopathic hemorrhage | 90 mcg/kg IV (off-label) |
| Ondansetron | PONV from blood (nausea/vomiting in hypovolemia) | 4mg IV |
Examiner's Tip (RGUHS 10-marker): This question frequently appears paired with "blood transfusion" or "massive hemorrhage management." Always include: (1) the MABL formula with a worked example, (2) ATLS classification table, (3) the gravimetric method with sponge volumes, (4) TEG/ROTEM brief mention, and (5) TXA dosing. Diagrams with the ATLS table and MABL calculation flowchart are high-yield for marks.